ClariVest Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

ClariVest Asset Management’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.45M	Hold
2024 Q2	$2.45M	Buy
2024 Q1	$2.79M	Buy